Lemaitre Vascular (LMAT) Short-term Investments (2017 - 2026)

Lemaitre Vascular (LMAT) has 10 years of Short-term Investments data on file, last reported at $340.4 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $340.4 million, up 22.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $340.4 million (up 22.79% YoY), and the FY2025 annual result was $330.9 million, up 20.71% from the prior year.
• Short-term Investments climbed to $340.4 million in Q1 2026 per LMAT's latest filing, from $330.9 million in the prior quarter.
• Over five years, Short-term Investments peaked at $340.4 million in Q1 2026 and troughed at $54.9 million in Q2 2022.
• A 5-year average of $155.3 million and a median of $81.7 million in 2024 frame the typical range for Short-term Investments.
• On a YoY basis, Short-term Investments climbed as much as 25751.4% in 2022 and fell as far as 13.28% in 2022.
• A 5-year view of Short-term Investments shows it stood at $63.6 million in 2022, then gained by 27.14% to $80.8 million in 2023, then surged by 239.23% to $274.1 million in 2024, then rose by 20.71% to $330.9 million in 2025, then gained by 2.87% to $340.4 million in 2026.
• Business Quant data shows LMAT's Short-term Investments at $340.4 million in Q1 2026, $330.9 million in Q4 2025, and $317.6 million in Q3 2025.